Yujiro S. Hata - Feb 27, 2025 Form 4 Insider Report for IDEAYA Biosciences, Inc. (IDYA)

Role
President and CEO, Director
Signature
/s/ Andres Ruiz Briseno, as Attorney-in-Fact for Yujiro Hata
Stock symbol
IDYA
Transactions as of
Feb 27, 2025
Transactions value $
$0
Form type
4
Date filed
2/28/2025, 06:00 PM
Previous filing
Feb 19, 2025
Next filing
Mar 14, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDYA Stock Option (right to buy) Award $0 +600K $0.00 600K Feb 27, 2025 Common Stock 600K $20.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2025 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.